P-Hydroxysteroid
Dehydrogenase in Cultured Hippocampal Cells Reactivates Inert 11 -Dehydrocorticosterone, Potentiating Neurotoxicity Vidya Rajan, Christopher R. W. Edwards, and Jonathan R. Seckl Edinburgh University, Department of Medicine, Western Genera/ Hospital, Edinburgh EH4 2XU, United Kingdom 11 P-Hydroxysteroid dehydrogenase (1 1 /3-HSD) catalyzes the conversion of the glucocorticoid cotticosterone (cortisol in humans) to inert 11 -dehydrocot-ticosterone (cortisone). 11 P-HSD activity is present in the hippocampus, where it is induced by glucocot-ticoids and stress in vivo, prompting suggestions that the enzyme may attenuate the deleterious effects of chronic glucocorticoid excess on neuronal function and survival. Two isoforms exist: 11 P-HSDI , a bidirectional NADPH-dependent enzyme, and 11 P-HSD2, an NAD+-dependent exclusive 11 pdehydrogenase (corticosterone-inactivating enzyme). In this study, 1 l/l-HSDl activity and mRNA synthesis were demonstrated in primary fetal hippocampal cell cultures. Unexpectedly, the reaction direction in intact hippocampal cells was 11 p-reduction (reactivation of inert 11 -dehydrocotticosterone), although homogenization revealed that the enzyme was capable of 1 lp-dehydrogenation when removed from its normal cellular context. Dexamethasone
(1 Op7 M) increased 11 P-HSD activity in homogenates of hippocampal cultures (102% increase).
In intact hippocampal cells, dexamethasone induced 11 preductase, not dehydrogenase.
To determine the functional relevance of hippocampal 11 p-reductase, glucocorticoid potentiation of kainic acid neurotoxicity was examined. Pretreatment of hippocampal cells with cot-ticosterone reduced survival on kainate exposure. Hippocampal cell 11 p-HSD activity was potently inhibited by carbenoxolone.
Carbenoxolone had no effect on cell survival after kainate alone and did not alter the effect of corticosterone.
11 -Dehydrocotticosterone also potentiated kainate neurotoxicity; this effect was lost, however, if 11 P-HSD was inhibited with carbenoxolone.
Thus, hippocampal 11 fi-HSD seems to be a functional 11 P-reductase in intact cells. Measures to attenuate hippocampal 11 p-reductase may reduce neuronal vulnerability to glucocorticoid toxicity. Key words: NADPH; dexamethasone; glucocorticoids; carbenoxolone; corticosterone; kainic acid 11/3-Hydroxysteroid dehydrogenase (1 l@HSD) catalyzes the conversion of physiological glucocorticoids (corticosterone, cortisol) to inert 11-keto derivatives (11-dehydrocorticosterone, cortisone) (Monder and White, 1993) . In viva, llS-HSD ensures selective access of aldosterone over corticosterone to mineralocorticoid receptors (MRs) in the distal nephron Funder et al., 1988) ; MRs are otherwise nonselective and bind corticosterone with similar affinity to aldosterone in vitro (Arriza et al., 1987 (Arriza et al., , 1988 . When 11/3-HSD is congenitally absent or inhibited by licorice (or its derivative carbenoxolone), glucocorticoids illicitly occupy renal MRs, causing sodium retention and hypertension (Stewart et al., 1987 (Stewart et al., , 1990 . Glucocorticoids, which are released from the adrenal cortex in response to circadian or stress-induced activation of the hypothalamic-pituitary-adrenal axis, subserve many roles in homeostasis and the response to stress. The brain is a key target for glucocorticoid action, which is mediated via both MRs and lower affinity glucocorticoid receptors (McEwen et al., 1986a; de Kloet, 1991; Seckl and Olsson, 1995) . The hippocampus expresses a higher density of MRs than does the kidney, but these sites are occupied by corticosterone in vivo (de Kloet et al., 1975; Reul and de Kloet, 1985; McEwen et al., 1986a; de Kloet, 1991) , suggesting that llP-HSD is absent. However, several recent studies have demonstrated llP-HSD activity, immunoreactivity, and mRNA expression in hippocampal cells (neurons) (Moisan et al., 1990; Lakshmi et al., 1991; Sakai et al., 1992) , raising the possibility of an aldosterone-selective subset of hippocampal MRs (Moisan et al., 1990) . Indeed, some data suggest that a proportion of hippocampal aldosterone binding is not readily displaced by corticosterone (McEwen et al., 1986b) and that not all functions of aldosterone and corticosterone in the hippocampus are identical (de Kloet et al., 1983) . Administration of llP-HSD inhibitors alters functional activity in the hippocampus in vivo (Seckl et al., 1991) , although the mechanisms underpinning this effect are obscure. Hippocampal ll/?-HSD is induced by chronic glucocorticoid excess or stress (Low et al., 1994b) . Because chronic glucocorticoid excess exerts well documented deleterious actions on hippocampal cell function and survival (Landfield et al., 1978; Sapolsky et al., 1985 Sapolsky et al., , 1986 Sapolsky, 1992) , it has been postulated that such induction of lip-HSD is protective (Monder, 1991; Low et al., 1994b; Seckl and Olsson, 1995) . Nevertheless, the presence of 11/3-HSD activity in the hippocampus contradicts a majority of data, which indicate nonselective MRs at this site.
Recently, it has become apparent that there are at least two distinct ll@HSD isoforms (Seckl, 1993) . Target organs for aldosterone and the placenta express a high-affinity, NAD'-dependent enzyme (ll/%HSD2), which is an exclusive 11/3-dehydrogenase (corticosterone inactivating enzyme) Albiston et al., 1994) . In contrast, the liver-derived isoform (ll@HSDl) is a lower-affinity, NADP+/NADPH-dependent enzyme (Lakshmi and Monder, 1988; Agarwal et al., 1989) . Expression of llP-HSDl cDNA in a range of cell lines encodes either a bidirectional enzyme (Agarwal et al., 1989) or a predominant ll@-reductase (Duperrex et al., 1993; Low et al., 1994a) . ll@Reductase activity, best observed in intact cells, activates ll-dehydrocorticosterone to alter target gene transcription and differentiated cell function (Duperrex et al., 1993; Low et al., 1994b) . In homogenates of hippocampus, both dehydrogenation and reduction occur (Lakshmi et al., 1991) , but the reaction direction in intact cells is unknown. We therefore have examined llfi-HSD activity and its function in primary cultures of fetal hippocampal cells.
MATERIALS AND METHODS
Cell culture media were obtained from Gibco (Paisley, UK); corticosterone (B), 11-dehydrocorticosterone (A), poly-n-lysine, insulin, apo-transferrin, putrescine, sodium selenite, and progesterone were obtained from Sigma (Poole, UK (Low et al., 1994a) . Purity was typically >99%, monitored on HPLC.
Primaly hippocampal neuronal culture. The cell cultures were prepared according to a method derived from Mitchell et al. (1990) . The medium (pH 7.3) contained DMEM with Glutamax-I (0.086%), 10% fetal bovine serum (FBS) or donor horse serum (DHS), 15 mM HEPES, 100 IU/ml penicillin, and 100 pg/ml streptomycin and glucose increased to 0.2%. Day 18 fetuses were removed by laparatomy, and the hippocampi were dissected into HBSS containing 15 mM HEPES, pH 7.4. The cells were incubated in trypsin-EDTA for 20 min, washed, and mechanically dissociated by trituration. Cells were seeded at a density of 0.8-1.0 X 10h cells/ml of medium and plated on 35 mm Petri dishes previously coated with 0.025 mg/ml poly-D-lysine. The cells were cultured in a watersaturated atmosphere at 37"C, 10% CO,, for 3 d in the presence of serum, and then changed to defined (serum-free) medium (DMEM-F12 containing Glutamax-I, 10 p&ml insulin, 100 &ml transferrin, 60 pM putrescine, 20 nM sodium selenite, 20 nM progesterone. 100 IU/ml nenicillin. and 100 &ml streptomycin). The cells w&e maintained in this medium for 5 d with one-third of the medium changed every 3 d until experimentation. Under these conditions, the cultures contained 60-80% neurons with glia forming the remainder, as determined by immunostaining of specimen cultures with antisera to glial fibrillary axial protein and neuron-specific enolase.
ll@HSD activity. lip-Reductase and llj3-dehydrogenase activity were determined in intact primary hippocampal cells by the addition of 25 nM [3H]A or [3H]B to the medium, as described previously (Low et al., 1994a) . Aliquots of the culture medium were removed at intervals over 24 hr and put into ethyl acetate; the steroids were extracted, dried under N,, and suspended in 100 ml of ethanol containing 2.5 mg/ml cold A and B. Steroids were separated by thin-layer chromatography (TLC) in chloroform/95% ethanol (92:8), and bands were visualized under ultraviolet light and scraped into scintillation vials containing 3 ml of liquid scintillant (Cocktail T, BDH, Luttetworth, UK). The radioactivity in each fraction was determined, and enzyme activity was expressed as the percentage conversion to reaction product (Low et al., 1994a) . Blanks, "H-labeled steroids incubated in medium on dishes without cells and extracted as above, were subtracted.
ll/$Reductase and 11/3-dehydrogenase activity also were determined in homogenates of cultured hippocampal cells, broadly as described previously (Moisan et al., 1990; Low et al., 1994a) . Cells were washed with PBS and homogenized in Buffer C [20 mM tricine, 1.07 mM (MgCO,),*Mg(OH),*5H,O, 2.67 mM MgSO,, 0.1 tnM EDTA, 33.3 mM DTT, and 0.2 mg/ml coenzyme A] containing 0.1% Triton X-100. Protein was measured by Bradford's method (Bio-Rad protein assay kit, Bio-Rad, Hemel Hempstead, UK). Preliminary studies established conditions such that the amount of protein added was within the linear portion of the relationship between protein concentration and percentage substrate conversion. Thus, an aliquot of hippocampal cell homogenate (typically 64 pg protein/ml) was incubated at 37°C for 60 min with 10 IIM [3H]B (lip-dehydrogenase) or [3H]A (lip-reductase), 400 pM NADP+ or NADPH. and PBS to a total volume of 50 nl. Steroids were extracted and separated by TLC, and enzyme activity' was calculated. Blanks were subtracted.
ll@HSD mRNA analysis. Expression of llP-HSDl and ll@HSD2 mRNA was determined by PCR. In brief, total RNA was extracted from cell homogenates with guanidinium thiocyanate (Chomczynski and Sacchi, 1987) . One microgram of RNA was subjected to reverse transcription in a total volume of 20 ~1 using the Promega Reverse transcription kit (Promega, Southampton, UK). A 2 ~1 aliquot of the reverse transcription reaction was used in the PCR reaction after denaturation at 96°C for 10 min. The PCR mix contained 1.5 mM MgCI,, 40 pM dNTPs, 20 pmol of each primer, and 2.5 U of Taq DNA polymerase in a final volume of 50 ~1. The primer pairs for 11/3-HSDl were 869P (5'~AAAGCTTGTCACQ TGGGGCCAGCAAA-3'), corresponding to nucleotides 178-207 of rat lIP-HSDl cDNA, and 868P (5'-AGGATCCAGfAAGCAAACT-GCT-TGCA-3'), complementary to nucleotides 648-628 of rat ll&HSDl cDNA. The primer pairs for llfl-HSD2 were P2520 (5'~CAATGCTG-GCCTCAACATGGT-3').
corresoondine to nucleotides 624-644 of the rat ll@-HSD2 cDNA, and P25'21 (5'~GGTCCTGGGTTGTGTCAT-GAA-3') complementary to nucleotides 1297-1277 of the rat lip-HSD2 cDNA sequence (Zhou et al., 1995) . Both sets of primers span intron sequences to distinguish DNA products (>4 kb for llS-HSDl, -0.93 kb fo;llP-HSD2) from mRNA products (0.43 kb for ll$HSDl, 0.63 kb for llB-HSD2). The PCR conditions were 30 cvcles of 96°C for 30 sec. 50°C for 45 set, and 72°C for 90 set, followed by extension at 72°C for 16 min.
Modulation of 11/3-HSD activity in primary hippocampal cells. To determine whether llfi-HSD activity in intact hippocampal cells was inhibited by licorice derivatives, cultures were pretreated with carbenoxolone (lo-" M) for 24 hr, and enzyme activity in lip-reductase and 11/3-dehydrogenase directions was estimated, as above. Glucocorticoid effects on enzyme activity were determined by preincubation of cultured hippocampal cells with dexamethasone (lo-' M) for 72 hr before enzyme measurement in intact cells after 8 hr incubation with 'H-labeled steroids (a period chosen to reflect submaximal 11/3-reductase and detectable lip-dehydrogenase activities).
Effects of IIP-HSD on hippocampal cell vulnerability to kainate toxicity. To determine the functional relevance of 11/3-HSD activity in primary cultures of hippocampal cells, the effects of corticosterone and ll-dehydrocorticosterone in the presence or absence of carbenoxolone on cell survival in response to kainic acid stimulation were determined, as described previously (Sapolsky, 1986; Packan and Sapolsky, 1990) . In brief, cells were cultured as described above, but in the presence of 2% FBS to improve cell survival in the presence of kainic acid. This did not alter the predominant llP-reduction in intact hippocampal cells or affect enzyme activity levels: corticosteroid levels are <10-i" M in FBS (S.C. Low and J. R. Seckl, unpublished observations.) Plates of cells were pre-exposed to 11-dehydrocorticosterone (10e5 M) or corticosterone (lo-' M) in the presence or absence of carbenoxolone ( 10m6 M) for 24 hr. Controls included cultures exposed to carbenoxolone alone and cultures to which nothing was added. All cells then received kainic acid (10m5 M). After 48 hr, cells were washed in PBS, scraped into 1.2 ml of potassium phosphate buffer, pH 7.5, containing 0.5% Triton X-100, and lactate dehydrogenase activity was determined, using a kit (Sigma) according to the instructions of the manufacturer, as a measure of cell survival (Sapolsky, 1986; Packan and Sapolsky, 1990) . Control plates that were not exposed to steroid or carbenoxolone were taken to represent 100% survival, and blanks represented 0% survival.
Statistics. Three to eight plates of cells were used for each data point. Data were assessed by ANOVA followed by Newman-Keulspost hoc test or Student's t tests, where appropriate. Significance was set at p < 0.05. Values are mean 2 SEM. RESULTS 1 1 /3-HSD in cultured hippocampal cells Primary fetal hippocampal cell cultures showed clear 11/3-HSD activity in cell homogenates. NADP+-dependent llp-dehydrogenase and NADPH-dependent llP-reductase activity was clearly detectable after 1 hr incubation (Fig. 1) . NAD+-dependent activity was only just above basal enzyme activity (with no added cosubstrate; Fig. 1 ). PCR analysis showed clear expression of llfl-HSDl mRNA, but no detectable expression of 11/3-HSD2 mRNA (Fig. 2) . Northern analysis showed only one hybridizing species of llP-HSDl transcript, identical in size to the transcript in rat liver (data not shown), confirming previous studies of 11/3-HSDl transcripts in adult and fetal rat hippocampus in vivo (Moisan et al., 1990 (Moisan et al., , 1992 Low et al., 1994b) . In contrast, predominant lip-reduction was found (Fig. 3) in intact hippocampal cells, with clearly detectable conversion of inert ll-dehydrocorticosterone to corticosterone within 30 min of addition of steroid, and 78% conversion after 24 hr. This represented plateau activity because no further conversion occurred after 48 hr incubation with [3H]A (data not shown). llfi-Dehydrogenase activity only became detectable after 8 hr incubation with [3H]B (4 t 1% conversion) and reached a mere 6.5 + 1% conversion at 24 hr (Fig. 3) . Pretreatment of cultures with the llP-HSD inhibitor carbenoxolone (low6 M) almost completely inhibited enzyme activity in intact hippocampal cells in 0.01 for lip-reductase activity compared with either carbenoxolone-inhibited lip reductase or 11/3-dehydrogenase at the same time point. both lip-reductase (Fig. 3) and llP-dehydrogenase (data not shown) directions.
Glucocorticoid modulation of hippocampal cell 1 l@HSD activity Treatment of primary hippocampal cell cultures with dexamethasone (10K7 M) for 72 hr increased l@HSD activity in cell homogenates (102% increase in lip-dehydrogenase, 72% increase in lip-reductase). In intact cells, this was exclusively an increase in 11/3-reductase activity (by 43%) with no alteration in dehydrogenation detected (Fig. 4) .
Effect of 11 j3-HSD on hippocampal cell survival in the presence of kainic acid Preliminary experiments showed that both 10V7 and lo-' M corticosterone potentiated kainic acid-mediated neurotoxicity, but this was considerably more apparent with the higher dose (data not shown). We therefore used the 10V5 M dose to study the effect of llP-HSD in these cells. In the presence of corticosterone, kainic acid exerted significantly greater neurotoxicity than did kainic acid alone (Fig. 5) , confirming previous studies (Sapolsky, 1986; Packan and Sapolsky, 1990) . Carbenoxolone (1O-6 M) did not alter the effect of corticosterone (lo-' M) on hippocampal cell loss in the presence of corticosterone, nor did 10e6 M carbenoxolone alone affect cell loss in the face of kainic acid stimulation (Fig. 5) . 11-Dehydrocorticosterone (10V5 M) also potentiated kainic acid neurotoxicity and was at least as potent in this action as corticosterone (Fig. 5) . However, inhibition of 11/3-HSD with carbenoxolone (10V6 M) abolished the cytotoxic potentiating effects of 11-dehydrocorticosterone in hippocampal cultures. DISCUSSION These studies clearly demonstrate llfl-HSD activity in primary hippocampal cell cultures. A majority of the cultured cells were neurons, and it seems likely that the activity, taken together with previous immunocytochemical and in situ hybridization data showing a predominant neuronal localization of ll@HSD in several brain regions in vivo (Moisan et al., 1990; Sakai et al., 1992) , reflects lip-HSD largely in neurons in the fetal hippocam- 
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Cel l s lzzl dexamethasone 11 R-reductase pal cultures. llP-HSD activity was detectable in culture for more than 8 d, suggesting that it is stable under the conditions that were used. In intact hippocampal cells, lip-reduction was clearly the predominant reaction direction. Dehydrogenation was barely detectable in intact hippocampal cells, and at the 8 hr time point at which 11/3-dehydrogenation became detectable and llp-reduction had not reached plateau values, the ratio of reduction to dehydrogenation was 11S:l. Few previous studies have addressed the reaction direction of 11/3-HSD in brain in viva. Those reported have used peripheral injection of radiolabeled glucocorticoids and have examined the concentrations of 11-hydroxy to ll-keto products in target tissues (Burton and Tufnell, 1967) . Uptake into the brain is low using such approaches, and in any event the data are complicated by peripheral conversion of steroids before entry into the brain, which largely reflects the balance of 11/3-reduction in the liver and 11/3-dehydrogenation in the kidney. No studies have examined 11/3-reduction in brain in vivo, and indeed it is difficult to envisage satisfactory experimental protocols to overcome peripheral interconversion of corticoids without their direct infusion into the central nervous system. In contrast, in homogenates of hippocampal cells, llp-dehydrogenase was readily detectable and indeed exceeded 11/3-reductase activity. This confirms studies in homogenates of hippocampus in vivo, which show both dehydrogenation and reduction reactions (Lakshmi et al., 1991; Seckl et al., 1993) . The basis for the discrepancy between predominant reduction in intact cells and dehydrogenation in homogenates of these cells is unclear but not unique to the hippocampus. Thus, transfection of COS7 cells with an expression plasmid encoding 11/3-HSDl produces exclusively ll@-reductase activity in intact cells, but potent dehydrogenation is revealed when the transfected cells are homogenized (Low et al., 1994a) . Reaction direction has been suggested to be determined by the glycosylation status of the enzyme or the tissue cosubstrate condition (Agarwal et al., 1990; Monder and White, 1993) . Variations in glycosylation cannot explain near-exclusive reduction in intact hippocampal cells when dehydrogenation predominates immediately after these cells are homogenized. Moreover, any variations in NADP+/NADPH ratios are unlikely to be sufficient to account for the dramatic change in reaction direction observed, and even gross changes in these ratios in intact cells (Jamieson et al., 1995) . Thus, it seems more likely that the subcellular context of the enzyme determines the reaction direction, with homogenization disrupting this. Whether or not the reductase component is unstable in homogenates, it is clear from these data that dehydrogenation is revealed by cellular disruption, but it is at most a minor reaction in intact hippocampal cells and, by implication, in the hippocampus in vivo. The lack of 11/3-dehydrogenation in intact hippocampal cell cultures also concurs with the nonselectivity of hippocampal MRs in vivo (de Kloet et al., 19751991; Reul and de Kloet, 1985; McEwen et al., 1986a) . Whether 11/3-HSD2 (an exclusive dehydrogenase) is present in the hippocampus is still debatable. Northern analysis shows no expression of lip-HSD2 mRNA in whole (human) brain I * " control A A+CBX B B+CBX CBX Figure 5 . Effect of pretreatment with corticosterone (B; 10m5 M) and ll-dehydrocorticosterone (A; lo-" M) with or without carbenoxolone (CBX, 1Om6 M) on hippocampal cell loss after exposure to kainic acid (10W5 M). Carbenoxolone alone has no effect on cells and does not alter the neurotoxic potentiation of corticosterone (B YS B+CBX). However, 11-dehydrocorticosterone (A) toxicity is prevented by carbenoxolone (A vs A+CBX), indicating that hippocampal cell lip-HSD acts as a functional 11/3-reductase in this model. *p < 0.05 compared with control; 'p < 0.05 compared with A alone. (Albiston et al., 1994) , and in situ hybridization studies have failed to find ll@HSD2 mRNA in the adult rat hippocampus (Roland et al., 1995) . In contrast, a recent PCR-based study showed lip-HSD2 transcripts in adult hippocampus (Zhou et al., 1995) . Using a similar PCR approach, however, we could not detect lip-HSD2 mRNA in primary hippocampal cell cultures and, importantly, found little NAD+-dependent bioactivity. Thus, hippocampal expression of this MR-protective 11/3-HSD isoform is probably negligible, at least in adult and late fetal life.
Previous studies have shown that chronic glucocorticoid (dexamethasone) excess or stress increase 11/3-HSDl mRNA expression and enzyme bioactivity (measured as dehydrogenation in homogenates) in the rat hippocampus (Low et al., 1994b) . Because treatment of primary hippocampal cultures with dexamethasone increased lip-HSD activity, it is probable that this effect of glucocorticoids is mediated directly on hippocampal neurons, and there is a putative glucocorticoid response element in the promoter of the rat llfl-HSDl gene (Moisan et al., 1992) . Moreover, preliminary data from transfection experiments with plasmids in which lip-HSDl promoter DNA is fused to a reporter gene suggest that a functional glucocorticoid response element lies within 3700 base pairs of the transcription start site (K. E. Chapman, M. Voice, R. Wallace, V. Lyons, and J. R. Seckl, unpublished observations) . Although it has been proposed that induction of lip-HSD in the hippocampus may protect vulnerable neurons from the deleterious consequences of chronic glucocorticoid excess (Monder, 1991; Low et al., 1994b) , the activity induced by dexamethasone was exclusively 11/3-reductase, a finding incompatible with this notion. Thus, hippocampal ll@HSD may potentiate rather than attenuate the neurotoxic effects of chronic glucocorticoid overexposure.
To examine this further, the effects of enzyme inhibition in both reductase and dehydrogenase directions was determined by using carbenoxolone. Potentiation of kainic acid neurotoxicity with lo-' and lo-' M corticosterone was found in primary hippocampal cell cultures, confirming previous studies (Sapolsky, 1986; Packan and Sapolsky, 1990) . Although supraphysiological levels of steroids were used in vitro, physiological concentrations (lo-' M) are effective in potentiating kainic acid neurotoxicity in this system (Packan and Sapolsky, 1990 ; and these data), although the changes were small during the short time course used here. In viva, corticosteroid effects take many days to become manifest (Sapolsky et al., 198 .5), and we have used higher concentrations to amplify effects in cell cultures. That the effect of corticosterone was unaltered by carbenoxolone in a dose that inhibited both reaction directions but had no direct effect on cell survival supports the relative lack of importance of lip-dehydrogenation in these cells. ll-Dehydrocorticosterone, which has 104-fold lower affinity for receptors than does corticosterone (Ulmann et al., 1975; Armanini et al., 1983) , was at least as effective as corticosterone in potentiating kainic acid toxicity. The functionality of 11/3-reductase was clear, inasmuch as 11-dehydrocorticosterone was ineffective when llP-HSD was inhibited by carbenoxolone. These data support the predominant lip-reductase action of hippocampal llfl-HSD.
The reasons for an enzyme regenerating active glucocorticoids in the hippocampus are obscure. Hippocampal cells are exquisitely sensitive to glucocorticoid concentrations, with granular neuronal dysfunction and possibly death in the dentate gyrus after adrenalectomy (Sloviter et al., 1989; Gould et al., 1990 ) and pyramidal neuronal loss in the cornu ammonis with glucocorticoid excess (Landfield et al., 1978; Sapolsky et al., 1985 Sapolsky et al., , 1986 Sapolsky, 1985 Sapolsky, , 1992 Landfield and Eldridge, 1991) . In the rat, corticosterone levels are very low during the day but show a pronounced diurnal increase in the evening. The biological importance of this rhythm is unclear, but the maintenance of many constitutive cellular functions may require more than the minimal levels of circulating corticosterone that pertain during the majority of the day. Thus, local lip-reduction may increase corticosterone levels in specific tissues and, hence, 1 l-dehydrocorticosterone may form a circulating reservoir of inert corticosteroid for cellspecific activation (the apparent absence of ll@HSD2 in the hippocampus suggests that 11-dehydrocorticosterone comes from the periphery rather than from local cellular production). Certainly in humans, cortisone (the equivalent of ll-dehydrocorticosterone) shows near-constant levels throughout the 24 hr period. Moreover, plasma concentrations of cortisone (which circulates largely unbound at -100 nmol/l) approximate or even exceed "free" cortisol levels, providing plentiful substrate for 11/3-reductase (Walker et al., 1992) . Similarly, levels of lldehydrocorticosterone at -50 nmol/l are found in rat plasma (R. Best and J. R. Seckl, unpublished observations), concentrations well in excess of "free" corticosterone levels during the diurnal nadir. Such cell-specific activation of an inert circulating form is not unique to glucocorticoids and may be analogous to the activation of thyroxine to tri-iodothyronine by 5'-monodeiodinase and testosterone to dihydrotestosterone by Sa-reductase in other tissues.
Why the activity of hippocampal 1 lp-reductase should increase with chronically elevated glucocorticoids also is unclear, because this seems to increase the neuron-jeopardizing effects of glucocorticoid excess. Perhaps the short-and medium-term metabolic and functional benefits of maximizing glucocorticoid exposure during stress outweigh any long-term detriments, particularly because potent negative feedback effects would be expected to rapidly attenuate glucocorticoid levels under most physiological circumstances. Further determination of the importance of hippocampal 11/3-HSD activity will be assisted by the development of selective Ilo-reductase inhibitors or transgenic animals lacking 11/3-HSDl. Nevertheless, it is intriguing to speculate that measures to attenuate hippocampal lip-reductase may reduce neuronal vulnerability to glucocorticoid toxicity in a target-specific manner, analogous to the effects of long-term maintenance of more generalized low glucocorticoid levels by adrenalectomy (Landfield et al., 1978) or increasing sensitivity to glucocorticoid negative feedback (Sapolsky et al., 1984; Meaney et al., 1988 Meaney et al., , 1993 Seckl and Olsson, 1995 
